companydata.dkNORDIC BIOTECH PRIVATE INVESTORS ApS: Financial statements 2012
CVR: 26284384
NORDIC BIOTECH PRIVATE INVESTORS ApS (CVR 26284384) has filed annual accounts for 2012. In 2012, the company reported a net result of DKK 15,355,683. Equity amounted to DKK 20,023,752. The solvency ratio was 99.9%.
- Profit/Loss
- 15,355,683 kr.
- Equity
- 20,023,752 kr.
- Total Assets
- 20,034,101 kr.
How creditworthy is NORDIC BIOTECH PRIVATE INVESTORS ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2012
As of May 30, 2012, Florian Schønharting has left the board of directors of NORDIC BIOTECH PRIVATE INVESTORS ApS.
As of May 30, 2012, Florian Schønharting is registered as director of NORDIC BIOTECH PRIVATE INVESTORS ApS.
About NORDIC BIOTECH PRIVATE INVESTORS ApS
NORDIC BIOTECH PRIVATE INVESTORS ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2001. The company was registered under the industry Ikke-finansielle holdingselskaber. The management consists of Jakob Mosegaard Larsen. The company's owners include Thue Walter Schwartz, Peter Moldt and Dorte Kloppenborg Skrumsager. In 2025, the company reported a gross profit of DKK -432,293 and a net result of DKK -571,396 compared with DKK 2,080,087 the year before. Equity amounted to DKK 2,975,449.